Biography
Dr. Yusuf TUTAR obtained his M.Sc. and Ph.D. at Oregon State University and Texas Tech University respectively. He pursued his postdoctoral study at National Institutes of Health (NIH/NIDDK), USA. His research focuses on Biochemistry, Biophysics, Genetics, and Molecular Biology with specialization in the fields of protein structure-function, protein folding, prion, microrna, pseudogenes, molecular cancer, proteomics, genomics, protein expression and characterization by spectroscopic and calorimetric methods. Dr. Tutar currently continue his research on drug design at University of Health Sciences, Istanbul, Turkey.
Research Interest
• Molecular Cancer Research and epigenetic (RT-PCR and Microarray). • MicroRNA, pseudogenes, and transfection. • Prion, translation termination in eukaryotes, and transcription initiation in prokaryotes. • Investigating structure-function relationship of biological macromolecules with biochemical, biophysical, genetics and molecular biological methods. • Recombinant DNA technology, molecular sub-cloning, transformation and protein expression. • Drug design, docking, molecular dynamics. • Nanoparticles for drug targeting. • Protein purification (Heat shock, Catabolite repressor and S100P proteins) and characterisation (Spectroscopy: Fluorescence, Luminescence, CD, FTIR; Calorimetry: NanoDSC and ITC; Chromatography: HPLC and FPLC; Other techniques: MALDI-TOF, GC, SPR)
Related Publications
-
Application of Enzymes: As an Emerging Pharmaceutical Research
Short Article: Arch Med Biotechnol 2018, 1:2
DOI:
Sharma M
-
Isolation and Characterization of Starter Culture Bacteria for Ensete Ventricosum Fermentation
Research Article: Arch Med Biotechnol 2018, 1:2
DOI:
Meskerem Elfu
-
Inhibitory Action of Essential Oils on Quorum Sensing Activity of Pseudomonas Aeruginosa by Effecting on Pyocyanin Production
Research Article: Arch Med Biotechnol 2018, 1:2
DOI:
Ali Abdul Hussein S AL Janabi
-
Literature Based Pharmacochemical Information of Caesalpinia pulcherima
Short Communication: Arch Med Biotechnol 2018, 1:2
DOI:
Rashidi Dachi
-
Evaluating the Technical Infrastructure of Electronic Health Record System (SEPAS)
Research Article: Arch Med Biotechnol 2018, 1:2
DOI:
Fharzane Balochzahe Shahbakhsh
-
Commentary on Anticonvulsant and Neuroprotective Effects of Walnuts Neurons of Brain Cortex
Commentary: Arch Med Biotechnol 2021, 2:1
DOI:
Jason Myers*
-
Multiple Phenotypic Expressions of Patients Affected by Cystic Fibrosis
Short Communication: Arch Med Biotechnol 2021, 2:1
DOI:
Steven Clark*
-
Perspective on the Pathenogenetic Development of Ovine Oocytes Maturation
Perspective: Arch Med Biotechnol 2021, 2:1
DOI:
Lucas Anderson*
-
Techniques Involved in Recombinant Deoxy Ribonucleic Acid (DNA) and Genetics
Rapid Communication: Arch Med Biotechnol 2021, 2:1
DOI:
Jing Chang*
-
The Use of Biotechnology in the Diagnosis and Treatment of Various Diseases
Opinion Article: Arch Med Biotechnol 2021, 2:1
DOI:
Aldene Russo*
-
The Promise of Bacteriophage Antimicrobial Therapeutics
Editorial: Arch Med Biotechnol 2018, 1:1
DOI:
D. Michael Olive and Joseph O’Connor
-
3D Cell Culture to Analyze Tumor Cell Nanovesicles Role in Prostate Cancer Pathogenesis
Research Article: Arch Med Biotechnol 2018, 1:1
DOI:
Faria RO, Moraes DD, Souza AG, Silva IBB and Alonso-Goulart V
-
The Role of Virus Receptor Recognition in the Determination of Pathogenesis
Review Article: Arch Med Biotechnol 2018, 1:1
DOI:
Aliyu Adamu, Aminu HA, Firdausi Aliyu and Mienda BS
-
Animal Model for Glioma: A Brief Overview
Review Article: Arch Med Biotechnol 2018, 1:1
DOI:
Phanithi Prakash Babu and Ravindra Pramod Deshpande
-
Prevalence of Women Taking Iron-Folic Acid (IFA) During Pregnancy and its Impact on Childâs Birth Weight
Research Article: Arch Med Biotechnol 2018, 1:1
DOI:
Deo Sushma, Pandey Shila and Kharel Sushil